Evidence map›Paper›PMID 28174489›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2016

Zheng Wang, Xiaonan Wu, Xiaohong Han, Gang Cheng, Xinlin Mu, Yuhui Zhang, Di Cui, Chang Liu, Dongge Liu, Yuankai Shi

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Detection ofBioMed research international · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Zheng WangDepartment of Pathology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Xiaonan WuDepartment of Medical Oncology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Xiaohong HanDepartment of Medical Oncology, National Cancer Center/Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Gang ChengDepartment of Medical Oncology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Xinlin MuDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing 100044, China.
Yuhui ZhangBeijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Di CuiDepartment of Pathology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Chang LiuDepartment of Medical Oncology, PLA Army General Hospital, Beijing 100700, China.
Dongge LiuDepartment of Pathology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Yuankai ShiDepartment of Medical Oncology, National Cancer Center/Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Beijing Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNCapital Medical University · CNPeking University · CNPeking University People's Hospital · CNThe Military General Hospital of Beijing PLA · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe relationship between anaplastic lymphoma kinase (

methodsVentana anti-ALK (D5F3) rabbit monoclonal primary antibody testing was performed on 313 cell blocks of MPE samples from Chinese patients with advanced lung adenocarcinoma, and fluorescence

resultsOf the 313 MPE samples, 27 (8.6%) were confirmed as

conclusionsThe

Indexed as

Anaplastic lymphoma kinasecrizotinibfluorescence in situ hybridizationimmunohistochemistrylung adenocarcinomapleural effusion

Identifiers

PMID28174489
PMCPMC5242450
OpenAlexW2573635060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.